This page includes the latest FDA filings for Enzyvant Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Sumitomo Pharma America, Inc. | Prescription Medication | 2023-12-08 |
Sumitomo Pharma America, Inc. | Prescription Medication | 2023-07-18 |
Sumitomo Pharma America, Inc. | Prescription Medication | 2023-03-01 |
Sumitomo Pharma America, Inc. | Prescription Medication | 2023-01-05 |
Sumitomo Pharma America, Inc. | Prescription Medication | 2021-10-23 |
Enzyvant Therapeutics Inc. | RETHYMIC | 2021-10-08 |